Acute and maintenance ECT with flupenthixol in refractory schizophrenia: Sustained improvements in psychopathology, quality of life, and social outcomes

Schizophrenia Research

Volumn 63, Issue 1-2, 2003, Pages 189-193

  Chanpattana, Worrawat ^a   Kramer, Barry Alan ^b  

^a SRINAKHARINWIROT UNIVERSITY   (Thailand)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

ECT; MECT; Quality of life; Schizophrenia; Treatment resistant

Indexed keywords

FLUPENTIXOL;

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; MINI MENTAL STATE EXAMINATION; OUTCOMES RESEARCH; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SCHIZOPHRENIA; SOCIAL STATUS;

EID: 0042206786     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(02)00330-4     Document Type: Conference Paper

References (22)

1. Agarwal A.K., Andrade C., Reddy M.V. The practice of ECT in India: issues relating to the administration of ECT. Indian J. Psychiatry. 34:1992;285-297.
2. Practice Guidelines for the Treatment of Patients with Schizophrenia. 1997;APA Press, Washington, DC.
3. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. 2nd ed. 2001;APA Press, Washington, DC.
4. Breier A., Buchanan R.W., Irish D., Carpenter W.T. Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns. Hosp. Community Psychiatry. 44:1993;1145-1149.
5. Chakos M., Lieberman J., Hoffman E., Bradford D., Sheitman B. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am. J. Psychiatry. 158:2001;518-526.
6. Chanpattana W. Maintenance ECT in treatment-resistant schizophrenia. J. Med. Assoc. Thail. 83:2000;657-662.
7. Chanpattana W., Chakrabhand S., Kongsakon R., Techakasem P., Buppanharun W. Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia. J. ECT. 15:1999;129-139.
8. Chanpattana W., Chakrabhand S., Sackeim H.A., Kitaroonchai W., Kongsakon R., Techakasem P., Buppanharun W., Tuntirungsee Y., Kirdcharoen N. Continuation ECT in treatment-resistant schizophrenia: a controlled study. J. ECT. 15:1999;178-192.
9. Fink M., Sackeim H.A. Convulsive therapy in schizophrenia? Schizophr. Bull. 22:1996;27-39.
10. First, M.B., Spitzer, R.L., Williams, J.B.W., Gibbon, M., 1995. Structured Clinical Interview for DSM-IV (SCID-I)-Research Version. New York, Biometrics Research Department, New York Psychiatric Institute.
11. Geddes J., Freemantle N., Harrison P., Bebbington P. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ. 321:2000;1371-1376.
12. Goldman H.H., Skodol A.E., Lave T.R. Revising axis V for DSM-IV: a review of measures of social functioning. Am. J. Psychiatry. 149:1992;1148-1156.
13. Heinrichs D.W., Hanlon T.E., Carpenter W.T. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr. Bull. 10:1984;388-397.
14. Kane J., Honigfeld G., Singer J., Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch. Gen. Psychiatry. 45:1988;789-796.
15. Kongsakon R., Vanichtanom R. Assessment of the differences in MMSE between neurological, psychiatric patients and normal population. J. Rajwithi Hosp. 5:1994;99-106.
16. Krueger R.B., Sackeim H.A. Electroconvulsive therapy and schizophrenia. Hirsch S.R., Weinberger D.R. Schizophrenia. 1995;503-545 Blackwell, Oxford, England.
17. Meltzer H.Y., Burnett S., Bastani B., Ramirez L.F. Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp. Community Psychiatry. 41:1990;892-897.
18. Overall J.E., Gorham D.R. The brief psychiatric rating scale. Psychol. Rep. 10:1962;799-812.
19. Pippard J., Ellam L. Electroconvulsion treatment in Great Britain. Lancet. ii:1981;1160-1161.
20. Rosenheck R., Cramer J., Xu W., Thomas J., Henderson W., Frisman L., Fye C., Charney D. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. N. Engl. J. Med. 337:1997;809-815.
21. Thompson J.W., Weiner R.D., Myers C.P. Use of ECT in the United States in 1975, 1980, and 1986. Am. J. Psychiatry. 151:1994;1657-1661.
22. Mental Health: A Report of the Surgeon General. 1999;Government Printing Office, Washington, DC.